Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-04-21 @ 11:20 AM
Study NCT ID:
NCT02690558
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-10
First Post:
2016-02-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-01-30
Completion Date Type:
ESTIMATED
First Submit Date:
2016-02-12
First Submit QC Date:
None
Study First Post Date:
2016-02-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-07-15
Results First Submit QC Date:
None
Results First Post Date:
2021-08-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-06
Last Update Post Date:
2025-02-10
Last Update Post Date Type:
ACTUAL